Delivery Order SPE2DB22D1052-SPE2DB25FU8FP

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $74,718.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VEMLIDY 25 MG TABLET, a prescription medication, and has a completion date of December 17, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which is valued at...
This federal contract award, valued at $57,920.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 24, 2024 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is the prime contractor, and there is no...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,532.24 firm fixed-price delivery order contract is for the supply of VEMLIDY 25 MG TABLET medical products. The contract has an ultimate completion date of January 10, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $6,736.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, with a completion date of November 13, 2024. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VEMLIDY 25 MG TABLET UU 30S. The $17,342.53 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which runs through November 2026. This IDC enables efficient government procurement of a...
This federal contract award, valued at $5,712.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $17,732.96, is a firm fixed price delivery order for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,686.29 firm fixed-price delivery order is for the supply of VEMLIDY 25 MG TABLET, a prescription medication. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,772.24 Firm Fixed Price Delivery Order contract provides the DLA with VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The award has a completion date of September 13, 2024. This contract is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,408.64 firm-fixed-price delivery order is for the supply of VEMLIDY 25 MG TABLET medication. The contract has an ultimate completion date of August 12, 2022 and was awarded on August 11, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
  • SPE2DB22D1052
    Indefinite Delivery Contract
  • SPE2DB22D1052-SPE2DB25FU8FP
    Delivery Order

This federal contract award, valued at $5,324.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product VEMLIDY 25 MG TABLET UU 30S, with an ultimate completion date of January 6, 2025. The contract type is firm fixed price. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 4/4/25, 9:47 AM